Alstonic acid A exhibits significant potential in pharmaceutical research due to its structural complexity and bioactivity. It has been investigated for its anti-inflammatory and neuroprotective properties, making it a candidate for development in treatments targeting neurodegenerative disorders such as Alzheimer's disease. Studies suggest it may modulate key enzymes involved in oxidative stress and neuronal damage. Additionally, its ability to interact with specific cellular signaling pathways highlights its relevance in oncology research, particularly in exploring mechanisms of apoptosis in cancer cells. Due to its natural origin and selective activity, it serves as a lead compound for synthesizing derivatives with enhanced therapeutic efficacy and reduced toxicity.